يعرض 1 - 19 نتائج من 19 نتيجة بحث عن '"O. A. Krokhina"', وقت الاستعلام: 0.54s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المصدر: Malignant tumours; Том 10, № 1 (2020); 21‑28 ; Злокачественные опухоли; Том 10, № 1 (2020); 21‑28 ; 2587-6813 ; 2224-5057

    وصف الملف: application/pdf

    Relation: https://www.malignanttumors.org/jour/article/view/716/492; Каприн А. Д., В. В. Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность) — М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России, — 2019. — илл. — 250 с.; Каприн А. Д., В. В. Старинский В. В., Петрова Г. В. Состояние онкологической помощи населению России в 2018 году. — М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019. илл.— 236 с.; Coombs N. J. Multifocal and Multicentric Breast Cancer: Does Each Focus Matter? / N. J. Coombs, J. Boyages // Journal of Clinical Oncology.— 2005.— Vol. 23.— № 30.— P. 7497–7502.; Egan R. L. Multicentric breast carcinomas: Clinical ‑ radiographic‑ pathologic whole organ studies and 10‑year survival / R. L. Egan // Cancer.— 1982.— Vol. 49.— № 6.— P. 1123–1130.; Fang M. Local Control of Breast Conservation Therapy versus Mastectomy in Multifocal or Multicentric Breast Cancer: A Systematic Review and Meta‑Analysis / M. Fang, X. Zhang, H. Zhang, et al. // Breast Care.— 2019.— Vol. 14.— № 4.— P. 188–193.; Houssami N. Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta‑Analysis in Detection of Multifocal and Multicentric Cancer / N. Houssami, S. Ciatto, P. Macaskill, et al. // Journal of Clinical Oncology.— 2008.— Vol. 26.— № 19.— P. 3248–3258.; Lagios M. D. Multicentricity of breast carcinoma demonstrated by routine correlated serial multicentric breast carcinoma subgross and radiographic examination / M. D. Lagios // Cancer.— 1977.— Vol. 40.— № 4.— P. 1726–1734.; Rosen P. P. «Residual» mammary carcinoma following simulated partial mastectomy / P. P. Rosen, A. A. Fracchia, J. A. Urban, et al. // Cancer.— 1975.— Vol. 35.— № 3.— P. 739–747.; Lim W. Breast Conserving Surgery for Multifocal Breast Cancer: / W. Lim, E.‑H. Park, S.‑L. Choi, et al. // Annals of Surgery.— 2009.— Vol. 249.— № 1.— P. 87–90.; Neri A. «Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases» / A. Neri, D. Marrelli, T. Megha, et al. // BMC Surgery.— 2015.— Vol. 15.— № 1.; Joergensen L. E. Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996–2001 / L. E. Joergensen, K. A. Gunnarsdottir, C. Lanng, et al. // The Breast.— 2008.Vol. 17.— № 6.— P. 587–591.; Fayers P., Aarson N., Bjordal K., Sullivan M. EORTC QLQ-C30 scoring manual. EORTC Study Group on Quality of Life. Brussels, 1995.; Sprangers, M. A. G., Groenvold, M., Arraras, J. I., et al. (1996). the EORTC breast cancer‑ specific quality‑ of‑life questionnaire module: First results from a three‑ country field study. J Clin Oncol / 1996 Oct;14 (10):2756–68. doi:10.1200/JCO.1996.14.10.2756.; Arndt V. Quality of life over 5 years in women with breast cancer after breast‑ conserving therapy versus mastectomy: a population ‑based study / V. Arndt, C. Stegmaier, H. Ziegler, et al. // Journal of Cancer Research and Clinical Oncology.— 2008.— Vol. 134.— № 12.— P. 1311–1318.; Engel J. Quality of Life Following Breast‑ Conserving Therapy or Mastectomy: Results of a 5‑Year Prospective Study / J. Engel, J. Kerr, A. Schlesinger‑Raab, et al. // The Breast Journal.— 2004.— Vol. 10.— № 3.— P. 223–231.; Howes B. H. L. Quality of life following total mastectomy with and without reconstruction versus breast‑ conserving surgery for breast cancer: A case‑ controlled cohort study / B. H. L. Howes, D. I. Watson, C. Xu, et al. // Journal of Plastic, Reconstructive & Aesthetic Surgery.— 2016.— Vol. 69.— № 9.— P. 1184–1191.; Shi H. Y. Two ‑year quality of life after breast cancer surgery: A comparison of three surgical procedures / H. Y. Shi, Y. H. Uen, L. C. Yen, et al. // European Journal of Surgical Oncology (EJSO).— 2011.— Vol. 37.— № 8.— P. 695–702.; Szutowicz ‑Wydra B. Same Quality of Life for Polish Breast Cancer Patients Treated with Mastectomy and Breast Reconstruction or Breast‑ Conserving Therapy. / B. Szutowicz‑Wydra, J. Wydra, W. Kruszewski, et al.— 2016.— Vol. 88.— № 5.— P. 264–269.; Janz N. K. Population‑based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer / N. K. Janz, M. Mujahid, P. M. Lantz, et al. // Quality of Life Research.— 2005.— Vol. 14.— № 6.— P. 1467–1479.; Heneghan H. M. Quality of life after immediate breast reconstruction and skin‑ sparing mastectomy — A comparison with patients undergoing breast conserving surgery / H. M. Heneghan, R. S. Prichard, R. Lyons, et al. // European Journal of Surgical Oncology (EJSO).— 2011.— Vol. 37.— № 11.— P. 937–943.; Zehra S. Health‑related quality of life following breast reconstruction compared to total mastectomy and breastconserving surgery among breast cancer survivors: a systematic review and meta‑analysis / S. Zehra, F. Doyle, M. Barry, et al. // Breast Cancer.— 2020.; https://www.malignanttumors.org/jour/article/view/716

  3. 3
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المصدر: Malignant tumours; № 2 (2013); 53-61 ; Злокачественные опухоли; № 2 (2013); 53-61 ; 2587-6813 ; 2224-5057

    وصف الملف: application/pdf

    Relation: https://www.malignanttumors.org/jour/article/view/33/37; Lynch H. T., Snyder C., Lynch J. Hereditary breast cancer: practical pursuit for clinical translation. Ann Surg Oncol. 2012 Jun;19 (6):1723 31.; Lalwani N., Prasad S. R., Vikram R. et al. Histologic, molecular, and cytogenetic features; of ovarian cancers: implications for diagnosis and treatment. Radiographics. 2011 May Jun; (3):625 46.; Любченко Л. Н. Наследственный рак молочной железы и / или яичников: ДНК диагностика, индивидуальный прогноз, лечение и профилактика [диссертация]. Москва 2009: РОНЦ им.Н. Н. Блохина (РАМН).; Имянитов Е. Н. Наследственный рак молочной железы. Практическая Онкология 2010; 11 (4): 258 66.; van der Groep P., van der Wall E., van Diest P. J. Pathology of hereditary breast cancer. Cell Oncol (Dordr). 2011 Apr;34 (2):71 88.; Lynch H. T., Casey M. J., Snyder C. L., et al. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol Oncol. 2009 Apr;3 (2):97 137.; Ferla R., Cal V., Cascio S. et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 2007; 18 (Suppl 6): 93 8.; Narod S. A., Foulkes W. D. BRCA1 and BRCA2: 1994 and beyond // Nat. Rev. Cancer. — 2004. — V. 4. — P. 665 676.; Chen S., Parmigiani G. Meta analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007; 25:1329 33.; Ford D., Easton D. F., Bishop D. T., Narod S. A., Goldgar D. E. Risks of cancer in BRCA1 mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343:692 5.; Ford D., Easton D. F., Stratton M. et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62:676 89.; Breast Cancer Information Core (BIC), web: research.nhgri.nih.gov / bic.; Поспехова Н. И. Комплексный анализ наследственной формы рака молочной железы и / или рака яичников: молекулярно генетические и фенотипические характеристики [диссертация]. Москва 2011: РОНЦ им.Н. Н. Блохина (РАМН).; Грудинина Н. А., Голубков В. И., Тихомирова О. С. и соавт. Преобладание широко распространенных мутаций в гене BRCA1 у больных семейными формами рака молочной железы Санкт Петербурга. Генетика 2005; 41 (3): 405 10.; Часовникова О. Б., Митрофанов Д. В., Демченко Д. О. и соавт. BRCA1 и BRCA2 мутации у больных раком молочной железы в сибирском регионе. Сибирский Онкологический Журнал 2010; 5: 32 5.; Батенева Е. И., Мещеряков А. А., Любченко Л. Н. и соавт. Частота одиннадцати мутаций генов BRCA1 и BRCA2 в неотобранной выборке больных раком молочной железы россиянок. Уральский Медицинский Журнал 2011, 03 (81): 69 73.; Iyevleva A. G., Suspitsin E. N., Kroeze K. et al. Non founder BRCA1 mutations in Russian breast cancer patients. Cancer Lett 2010; 298: 258 63.; Шубин В. П., Карпухин А. В. Молекулярная генетика наследственной предрасположенности к раку яичников // Медицинская генетика. — 2011. — Т.10. — № 4. — с.39 47.; Young S. R., Pilarski R. T., Donenberg T. et al. The prevalence of BRCA1 mutations among young women with triple negative breast cancer. BMC Cancer 9:86, 2009.; Graeser M. K., Engel C., Rhiem K. et al. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2009 Dec 10;27 (35):5887 92.; Gadzicki D., Evans D. G., Harris H. et al. Genetic testing for familial / hereditary breast cancer comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet. 2011 Jun;2 (2):53 69.; Balma a J,. Diez O., Rubio I., Castiglione M.; ESMO Guidelines Working Group. BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2010 May;21 Suppl 5: v20—2.; National Comprehensive Cancer Network. Clinical practice guidelines in oncology genetic / familal high risk assessment: breast and ovarian. Version 1. 2012. http://www.nccn. org / professionals / physician_gls / f_guidelines.asp.; Kwon J. S., Gutierrez Barrera A. M., Young D. et al. Expanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol. 2010 Sep 20;28 (27):4214 20.; Bigenwald R. Z., Warner E., Gunasekara A. Is mammography adequate for screening women with inherited BRCA mutations and low breast density? Cancer Epidemiol Biomarkers Prev. 2008 Mar; 17 (3):706 11.; Американское Онкологическое Общество, American Cancer Society, http://www.cancer. org / Cancer / index.; Domchek S. M., Friebel T. M., Singer C. F. et al. Association of risk reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010 Sep 1;304 (9):967 75.; Long K. C., Kauff N. D. Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies. Curr Opin Oncol. 2011 Sep;23 (5):526 30.; Boughey J. C., Hoskin T. L., Degnim A. C. et al. Contralateral prophylactic mastectomy is associated with a survival advantage in high risk women with a personal history of breast cancer. Ann Surg Oncol. 2010 Oct;17 (10):2702 9.; Grann V. R., Panageas K. S., Whang W. et al. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1 positive or BRCA2 positive patients. J Clin Oncol. 1998 Mar;16 (3):979 85.; https://www.malignanttumors.org/jour/article/view/33

  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19